Videos

RSS icon
Nicholas Marston, MD, MPH assistant professor of medicine, and a cardiologist at Brigham and Women's Hospital, presented the late-breaking VESALIUS-CV data on the use of evolocumab for the reduction of major cardiovascular events in patients who do not have significant atherosclerosis. #ACC26

Evolocumab reduces risk of major cardiac events in diabetic patients

Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial. 

Darryl Drevna, senior director of regulatory affairs, American Medical Group Association (AMGA), explains the issues that led to the current shortages of staff across healthcare, how government policy plays a role and ways that the problem can be addressed.

Ways to address the expanding healthcare staffing shortage

Healthcare systems tell AMGA they are competing with Home Depot and other retailers for front office staff.

Gregg Stone, MD, FACC, FSCAI, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai Hospital in New York, presented the results of the long-awaited STEMI Door or Unloading time trial, which takes a different approach to first using a percutaneous heart pump to unload the heart 30 minutes prior to PCI interventions to try and prevent common complications and improve outcomes.

Late-breaking PCI data challenge the 'time is muscle' paradigm

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

The U.S. healthcare system is facing a deepening workforce shortage driven by policy constraints, limited training capacity and immigration barriers—issues that could significantly worsen in the coming years without reforms, according to Anders Gilberg, senior vice president, government affairs at Medical Group Management Association (MGMA), in the above video interview. #MGMA #IMMIGRATION

MGMA supports bipartisan effort to eliminate $100K visa fee for healthcare workers

MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage.

One of the big late-breaking trials presented at the 2026 American College of Cardiology (ACC) Scientific Sessions was the CHAMPION-AF, which showed left atrial appendage occlusion (LAAO) can offer a safe, non-drug alternative to anticoagulation therapy, even in patients with atrial fibrillation who are not at high risk for bleeding. First author of the study Shephal Doshi, MD, FACC, an electrophysiologist at Cedars Sinai Smidt Heart Institute, discussed the details of the trial. #LAAO #ACC #ACC26

New data point to LAAO as a safe alternative to long-term drug therapy

At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.

Christoph Wald, MD, MBA, FACR, vice chair of the American College of Radiology (ACR) Board of Chancellors, professor of radiology and senior associate consultant for radiologist at Mayo Clinic, explains the ACR resources available to radiology practices to better evaluate artificial intelligence imaging algorithms.

American College of Radiology expands tools to help practices evaluate imaging AI

Incoming ACR board chair Christoph Wald, MD, explains the ACR resources available to radiology practices to better evaluate artificial intelligence imaging algorithms. 
 

Video interview with Society for Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, FACC, FAHA, MSCAI, explains the advancements in interventional cardiology the society has championed over the past year. #SCAI

Outgoing SCAI president reflects on a busy year full of partnerships and advocacy

SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months. 

Darryl Drevna, senior director of regulatory affairs, American Medical Group Association (AMGA), explains why the group objects to a near-complete freeze in an annual payment adjustment for Medicare Advantage (MA) plans, arguing it fails to keep pace with the real-world costs of delivering care to Medicare patients.

AMGA pushes back on Medicare Advantage payment adjustment and outlines needed reforms

The American Medical Group Association explains why it has issues with the payment adjustment for Medicare Advantage plans, arguing it fails to keep pace with the real-world costs.

Displaying 17 - 24 of 682
Design by Adaptive Theme